Partnership and innovation in the pharmaceutical industry: the case of clinical research
Giovanni Ramello and
Frederic M. Scherer
Economics of Innovation and New Technology, 2021, vol. 30, issue 3, 317-334
This study attempts to test the hypothesis that collaborative research projects boost R&D performance. More specifically, through an empirical investigation, it ascertains which organizational solution best enhances scientific impact, focusing on a sample of phase II and III clinical trials and using citations in scientific journals as a measure. The main findings confirm that there are substantial differences in the ability of distinct research organizations to foster innovation, with the collaborative solution more likely to be productive. All in all, this result supports the literature asserting that collaborative networks play a productive role in knowledge domains. It may also offer an explanation for the puzzle characterizing the pharmaceutical industry, where extensive consolidation has coincided with a fall in R&D productivity.
References: Add references at CitEc
Citations: View citations in EconPapers (1) Track citations by RSS feed
Downloads: (external link)
Access to full text is restricted to subscribers.
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:taf:ecinnt:v:30:y:2021:i:3:p:317-334
Ordering information: This journal article can be ordered from
Access Statistics for this article
Economics of Innovation and New Technology is currently edited by Professor Cristiano Antonelli
More articles in Economics of Innovation and New Technology from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().